Jeffrey Denney is an experienced Investment Director at GroupM, with a focus on digital strategy and media buying. For the past 4 years he has led the digital practice on the Novo Nordisk account, overseeing the media campaigns for Ozempic, WeGovy, and a range of other major product launches.
During his tenure at GroupM he has worked across a diverse range of business sectors, both as an investment manager and strategist, including Pharmaceutical (Novo Nordisk), Luxury (Tiffany & Co.), Fashion (Calzedonia, Helly Hansen), CPG (LaVazza, Alouette), Beauty (Clarins), B2B (Accenture), and Technology (Remarkeable). He has been involved in many successful brand launches, and award-winning campaigns, delivering strong business performance on behalf of our clients.